Early Career Travel Stipend Award
Nominations for the 2018 award will open next year.
Travel stipends are awarded annually to as many as four pediatric hematology/oncology fellows who have submitted high-quality abstracts as determined by the ASPHO Program Committee. Stipend winners are expected to present their abstracts during platform sessions at the ASPHO Annual Meeting.
The qualifications for the award candidates are as follows:
- The applicant is either currently a fellow in a pediatric hematology/oncology program or is within four years of completing a standard three-year pediatric hematology-oncology fellowship
- The individual’s abstract has been accepted for presentation either as a poster or platform session at the ASPHO meeting
- Author submits an application for funding
- Currently a member of ASPHO living in the United States or Canada
- Applicant has not received any other ASPHO awards this year
To apply, please include the following:
- A supporting letter from the training program director or the program chair, attesting to the applicant's status as well as his/her role in the conduct of the research project
- In regards to awards for a particular topic the letter should address the individual's interest in this area and how participation will advance this area of their career
Winners are chosen based on eligibility criteria, topic, and abstract ranking. The award consists of $500 and will be presented at the annual meeting.
2017 Early Career Travel Stipend Award Recipients
Jason Schwartz, MD PhD, St. Jude Children's Research Hospital, Memphis, TN
Ryan J. Summers, MD, Emory University School of Medicine, Decatur, GA
Michael Deel, MD, Duke University Medical Center, Durham, NC
Past Recipients of the Early Career Travel Stipend Award
These awards are supported by member donations to the Enriching the Future fund.
Waitman Aumann, MD, Duke University Medical School
The Role of CRM1 Dimerization in CRM1-AF10 Leukemogenesis
Jonathan Marron, MD, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Patient/Parent Perspectives on Genomic Tumor Profiling of Pediatric Solid Tumors: The Individualized Cancer Therapy (ICAT) Experience
Pillai Pallavi Madhusoodhan, MD, NYU Langone Medical Center
MSH6 Haploinsufficiency at Relapse Contributes to the Development of Thiopurine Resistance in Pediatric B-Lymphoblastic Leukemia
Nickhill Bhakta, MD, St. Jude Children’s Research Hospital
Use of the Cumulative Burden Approach to Assess Cardiovascular Morbidity Among Pediatric Hodgkin Lymphoma (HL) Survivors: A Report from the St. Jude Lifetime (SJLIFE) Cohort Study